Delivery Order SPE2DB24D1021-SPE2DB24FETRP

Award Date 8/27/24
Potential Completion Date 9/18/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a ceiling value of $25,920.62 and an ultimate completion date of September 4, 2024. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide the required medication to support the healthcare needs of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. The contract, which has a firm fixed price, has a ceiling value of $12,960.30 and an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment programs and facilities worldwide through its Indefinite...
This is a $27,693.94 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through June 12, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of November 12, 2024. This delivery order contract is a part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,602.01 firm fixed-price contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is part of AmerisourceBergen's IDC with DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for $69,234.85 and covers the supply of the medication VYNDAMAX 61 MG CAPSULE UD 30S. The contract is a firm fixed-price agreement, has an ultimate completion date of July 25, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has a ceiling value of $12,960.30 and an ultimate completion date of September 3, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for delivering the pharmaceutical product to support the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, at a firm fixed price of $12,960.30. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities,...
This is a $12,960.30 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, and has a period of performance through July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,408.24, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FETRP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 61 mg VYNDAMAX capsules. The contract has a firm fixed price of $12,960.30 and a completion date of September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 11/26/24, 9:09 AM